Evidence map›Paper›PMID 40178949›Full record

ArticleAIDS research and human retroviruses2025

Indicators for Increased Likelihood of Epidemic Kaposi Sarcoma Progression After Antiretroviral Therapy Initiation.

David J Nolan, Gary B Fogel, Jonathan DaRoza, Rebecca Rose, Paige M Bracci, Susanna L Lamers, Michael S McGrath

Abstract read
In one paragraph

Article in AIDS research and human retroviruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

David J NolanBioinfoexperts, LLC, Thibodaux, Louisiana, USA.ORCID 0000-0002-9114-7002
Gary B FogelNatural Selection, Inc., San Diego, California, USA.
Jonathan DaRozaBioinfoexperts, LLC, Thibodaux, Louisiana, USA.
Rebecca RoseBioinfoexperts, LLC, Thibodaux, Louisiana, USA.ORCID 0000-0002-5059-9176
Paige M BracciDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
Susanna L LamersBioinfoexperts, LLC, Thibodaux, Louisiana, USA.
Michael S McGrathDepartment of Medicine, The University of California at San Francisco, San Francisco, California, USA.

Funding

Pathogenesis of the cART unresponsive Kaposi’s sarcoma tumor nicheR01CA239263 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCGRATH, MICHAEL SHANNON · 2019 to 2023
$2.8M
NCI NIH HHS R01 CA239263
6 · The paper itself

Abstract

Kaposi sarcoma (KS) is a common malignancy for people living with HIV (PLWH), despite antiretroviral therapy (ART). Curiously, even with improved CD4

Indexed as

Anti-Retroviral AgentsHIV InfectionsSarcoma, KaposiAdultCD4 Lymphocyte CountDisease ProgressionFemaleHerpesvirus 8, HumanHumansMaleMiddle AgedViral LoadAnti-Retroviral Agentsantiretroviral therapyHIVKaposi sarcomaKSHV

Identifiers

PMID40178949
PMCPMC13148725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.